We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – Multimedia

Teach Me in 10 – Materials for Drug Delivery With Professor Robert Langer  content piece image
Video

Teach Me in 10 – Materials for Drug Delivery With Professor Robert Langer

For this installment of Teach Me in 10, we are joined by the renowned Professor Robert Langer – the most cited engineer of all time – who talks to us about materials for drug delivery.
Top 10 Cancer Research News Stories of 2020 content piece image
Listicle

Top 10 Cancer Research News Stories of 2020

This listicle details the top 10 most-read non-COVID-19 cancer research news stories from the field this year, published on Technology Networks.
COVID-19 Vaccine Efficacy Explained - It's Not What You Think content piece image
Video

COVID-19 Vaccine Efficacy Explained - It's Not What You Think

What does the COVID-19 Vaccine Efficacy actually mean? It's not what you think. Unless you’ve been living under a rock these past two weeks, you probably heard the great news that two of the leading vaccine contenders for COVID-19 have had some amazing initial results. Jeff Galak debunks some of the most common incorrect interpretation of those efficacy numbers and then explains to you what they actually mean.
How To Make a Vaccine in Record Time content piece image
Video

How To Make a Vaccine in Record Time

Vaccines usually take decades to develop – so how is Oxford University's ChAdOx1 nCoV-1 vaccine trial moving so quickly? It comes down to careful planning, extraordinary logistics and a whole lot of help from partners around the world.
Opinionated Science Episode 11: Biohacking: DIY Gene Editing, Fluorescent Beer and COVID-19 content piece image
Podcast

Opinionated Science Episode 11: Biohacking: DIY Gene Editing, Fluorescent Beer and COVID-19

In this episode, the team take a deep dive into the world of biohacking. Practitioners of this DIY biology have big goals: making genetic technologies available to all, bypassing government regulation of drugs and (on the fringes of the movement) achieving immortality.
LION Vaccine for COVID-19 Displays Protective Traits in Non-Human Primates content piece image
Video

LION Vaccine for COVID-19 Displays Protective Traits in Non-Human Primates

A replicating RNA vaccine, formulated with a lipid-based nanoparticle emulsion that goes by the acronym LION, produces antibodies against the COVID-19 coronavirus in mice and primates with a single immunization.
First Volunteers Receive Imperial COVID-19 Vaccine content piece image
Video

First Volunteers Receive Imperial COVID-19 Vaccine

The first healthy volunteers have now received a candidate coronavirus vaccine developed by Imperial researchers.
How Fast Can a Vaccine Be Made? content piece image
Video

How Fast Can a Vaccine Be Made?

When a new pathogen emerges, our bodies and healthcare systems are left vulnerable. And when this pathogen causes the outbreak of a pandemic, there’s an urgent need for a vaccine to create widespread immunity with minimal loss of life. So how quickly can we develop vaccines when we need them most?
Opinionated Science Episode 6: COVID-19: Repurposing Drugs, Hydroxychloroquine and Clinical Trials content piece image
Podcast

Opinionated Science Episode 6: COVID-19: Repurposing Drugs, Hydroxychloroquine and Clinical Trials

In this episode, the Technology Networks team discusses drug treatments to combat SARS-CoV-2. These drugs, like the anti-malarial hydroxychloroquine, have often been repurposed for the task, and evidence for their efficacy remains patchy. Why do researchers turn to these medications and how will the field of drug development be changed by the COVID-19 pandemic?
Meet the Subjects of the UK's First Coronavirus Vaccine Clinical Trial content piece image
Video

Meet the Subjects of the UK's First Coronavirus Vaccine Clinical Trial

This video features interviews with some of the participants in the UK clinical trial testing ChAdOx1 nCoV-19, a coronavirus vaccine candidate. They share their reasoning for partaking in the trial, their experience so far and their hopes for a positive outcome.
Advertisement